版本:
中国

BRIEF-Amarin reaches the onset of about 80 pct of the target aggregate number within the reduce-it study

March 16 Amarin Corporation Plc -

* Amarin reaches the onset of approximately 80% of the target aggregate number of primary major adverse cardiovascular events within the reduce-it study

* Currently expects independent interim analysis to be conducted before end of third calendar quarter of this year

* Amarin says will remain blinded to interim and ongoing results of reduce-it study until ready to be stopped at interim or final analysis Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐